NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 124 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41 | -60.6% | 38,861 | -3.8% | 0.00% | – |
| Q2 2023 | $104 | -41.9% | 40,390 | -8.4% | 0.00% | – |
| Q1 2023 | $179 | -48.9% | 44,077 | -36.9% | 0.00% | – |
| Q4 2022 | $350 | -99.9% | 69,904 | +59.3% | 0.00% | -100.0% |
| Q3 2022 | $575,000 | +76.4% | 43,895 | +72.6% | 0.00% | – |
| Q2 2022 | $326,000 | +10.5% | 25,436 | +31.3% | 0.00% | – |
| Q1 2022 | $295,000 | -85.1% | 19,371 | -82.6% | 0.00% | – |
| Q4 2021 | $1,974,000 | +190.7% | 111,520 | +245.7% | 0.00% | – |
| Q3 2021 | $679,000 | +452.0% | 32,261 | +420.2% | 0.00% | – |
| Q2 2021 | $123,000 | -84.1% | 6,202 | -76.7% | 0.00% | – |
| Q1 2021 | $773,000 | +57.1% | 26,569 | +63.6% | 0.00% | – |
| Q4 2020 | $492,000 | +21.8% | 16,238 | -36.1% | 0.00% | – |
| Q3 2020 | $404,000 | -10.2% | 25,396 | +11.2% | 0.00% | – |
| Q2 2020 | $450,000 | +63.0% | 22,830 | +2.0% | 0.00% | – |
| Q1 2020 | $276,000 | -65.5% | 22,381 | -48.3% | 0.00% | – |
| Q4 2019 | $800,000 | +99.5% | 43,314 | +49.8% | 0.00% | – |
| Q3 2019 | $401,000 | -6.3% | 28,916 | -1.3% | 0.00% | – |
| Q2 2019 | $428,000 | – | 29,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |